Literature DB >> 8258966

Molecular biology of erythropoietin.

P J Ratcliffe1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8258966     DOI: 10.1038/ki.1993.327

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  13 in total

1.  Plasma erythropoietin level and iron reserves in haemodialysis patients with and without acquired cystic kidney disease.

Authors:  M Majdan; A Ksiazek; M Kozioł; D Spasiewicz
Journal:  Int Urol Nephrol       Date:  1997       Impact factor: 2.370

Review 2.  Chronic kidney disease and its complications.

Authors:  Robert Thomas; Abbas Kanso; John R Sedor
Journal:  Prim Care       Date:  2008-06       Impact factor: 2.907

Review 3.  Systematic Review of Erythropoietin (EPO) for Neuroprotection in Human Studies.

Authors:  Salman Hemani; Olabisi Lane; Sunil Agarwal; Shan Ping Yu; Anna Woodbury
Journal:  Neurochem Res       Date:  2021-02-01       Impact factor: 3.996

4.  Frequency of alloantibodies among chronic renal failure patients in red sea state.

Authors:  Hythum Abdullah M Babiker; Tagwa Yousif Elsayed
Journal:  Indian J Hematol Blood Transfus       Date:  2013-02-12       Impact factor: 0.900

5.  An early effect of acute plasma volume expansion in humans on serum erythropoietin concentration.

Authors:  Z Szyguła; J Smitz; J Roeykens; K De Meirleir; T Klausen
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1995

6.  Changes of endogenous erythropoietin level and iron status during a 30-month hemodialysis treatment of a group of patients.

Authors:  M Majdan; A Ksiazek; A Bednarek-Skublewska; D Spasiewicz
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

7.  End Stage Renal Disease: Not a Contraindication for Minor Oral Surgery-Protocol for the Management of Oral Surgery patients with ESRD on Hemodialysis.

Authors:  Sneha Pendem; G Lakshmi Narayana; Poornima Ravi
Journal:  J Maxillofac Oral Surg       Date:  2016-07-28

8.  A mutation in the mouse Chd2 chromatin remodeling enzyme results in a complex renal phenotype.

Authors:  Concetta G A Marfella; Nils Henninger; Scott E LeBlanc; Namrata Krishnan; David S Garlick; Lawrence B Holzman; Anthony N Imbalzano
Journal:  Kidney Blood Press Res       Date:  2009-01-14       Impact factor: 2.687

9.  Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3' enhancer.

Authors:  J D Firth; B L Ebert; C W Pugh; P J Ratcliffe
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

10.  Erythropoietin producing cells for potential cell therapy.

Authors:  Tamer Aboushwareb; Fernanda Egydio; Lauren Straker; Kenneth Gyabaah; Anthony Atala; James J Yoo
Journal:  World J Urol       Date:  2008-07-08       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.